Form 4: Leonardo DRS EVP Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Mark Dorfman, EVP, GC and Secretary of Leonardo DRS, Inc., sold 10,014 shares of common stock for $45.27 per share under a pre-arranged 10b5-1 trading plan.

Summary

  • Mark Dorfman, Executive Vice President, General Counsel, and Secretary of Leonardo DRS, Inc., reported a sale of common stock.
  • On March 16, 2026, Dorfman disposed of 10,014 shares of Leonardo DRS common stock.
  • The shares were sold at a price of $45.27 per share.
  • Following this transaction, Dorfman beneficially owns 17,666 shares of common stock.
  • The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on June 13, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces direct ownership, the execution under a pre-arranged 10b5-1 plan suggests a planned personal financial move rather than a reaction to new company-specific information.

Positives

  • The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

  • An insider sale, even if pre-planned, reduces the insider's direct equity stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those under 10b5-1 plans, are common in the defense industry as executives manage their personal portfolios and compensation. This specific transaction does not inherently signal a change in the company's operational outlook or industry trends.

Comparison to Industry Standards

  • Insider sales under 10b5-1 plans are a standard practice across various industries, including defense contractors like Lockheed Martin, Raytheon Technologies, and Northrop Grumman, where executives often use such plans to diversify holdings or manage liquidity without implying a negative outlook on the company's future performance. This transaction aligns with typical executive compensation and personal financial planning strategies observed in comparable companies.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Attorney-In-FactNAOriana Pietrangelo02/20/2026Appointment to assist with SEC filings.
Attorney-In-FactNAKatherine Krebel02/20/2026Appointment to assist with SEC filings.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantMark Dorfman granted a Power of Attorney to Oriana Pietrangelo and Katherine Krebel to prepare, sign, and submit SEC filings (Forms 3, 4, 5, Schedules 13D/13G, Forms 144) on his behalf.02/20/2026Streamlines the process for executive SEC compliance filings, ensuring timely and accurate submissions.

Stakeholder Impact

  • Shareholders: The sale under a 10b5-1 plan typically has minimal impact on shareholder sentiment as it's a pre-planned event.

Key Dates

DateDescription
06/13/2025Date Rule 10b5-1 trading plan was adopted by Mark Dorfman.
02/20/2026Date Power of Attorney was executed by Mark Dorfman.
03/16/2026Date of transaction (sale of common stock by Mark Dorfman).
03/17/2026Date of filing of the Form 4.

Recommendation

hold

The insider sale by Mark Dorfman, while a reduction in direct ownership, was executed under a pre-arranged Rule 10b5-1 trading plan. This suggests a planned personal financial management decision rather than a reaction to new, adverse company information. Therefore, this event alone does not warrant a change in investment thesis, and a 'hold' recommendation is appropriate.

Keywords

Leonardo DRS, DRS, Form 4, Insider Trading, Stock Sale, Mark Dorfman, 10b5-1 Plan, Executive Compensation, Defense Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.